GB0312478D0 - Improved process - Google Patents

Improved process

Info

Publication number
GB0312478D0
GB0312478D0 GBGB0312478.1A GB0312478A GB0312478D0 GB 0312478 D0 GB0312478 D0 GB 0312478D0 GB 0312478 A GB0312478 A GB 0312478A GB 0312478 D0 GB0312478 D0 GB 0312478D0
Authority
GB
United Kingdom
Prior art keywords
improved process
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0312478.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GBGB0312478.1A priority Critical patent/GB0312478D0/en
Publication of GB0312478D0 publication Critical patent/GB0312478D0/en
Priority to MXPA05012838A priority patent/MXPA05012838A/es
Priority to PCT/IB2004/001694 priority patent/WO2004106327A1/en
Priority to EP04733602A priority patent/EP1633739A1/en
Priority to BRPI0410841-8A priority patent/BRPI0410841A/pt
Priority to JP2006530682A priority patent/JP2006528968A/ja
Priority to CA002527127A priority patent/CA2527127A1/en
Priority to CL200401132A priority patent/CL2004001132A1/es
Priority to US10/852,038 priority patent/US7132549B2/en
Priority to TW093114789A priority patent/TWI290923B/zh
Priority to ARP040101864A priority patent/AR044463A1/es
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
GBGB0312478.1A 2003-05-30 2003-05-30 Improved process Ceased GB0312478D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0312478.1A GB0312478D0 (en) 2003-05-30 2003-05-30 Improved process
CA002527127A CA2527127A1 (en) 2003-05-30 2004-05-18 Process for the preparation of anhydrous eletriptan hemisulphate
BRPI0410841-8A BRPI0410841A (pt) 2003-05-30 2004-05-18 processo para a preparação de hemissulfato de eletriptano anidro
PCT/IB2004/001694 WO2004106327A1 (en) 2003-05-30 2004-05-18 Process for the preparation of anhydrous eleptritan hemisulphate
EP04733602A EP1633739A1 (en) 2003-05-30 2004-05-18 Process for the preparation of anhydrous eleptritan hemisulphate
MXPA05012838A MXPA05012838A (es) 2003-05-30 2004-05-18 Procedimiento mejorado.
JP2006530682A JP2006528968A (ja) 2003-05-30 2004-05-18 無水エレトリプタンヘミサルフェートの製造方法
CL200401132A CL2004001132A1 (es) 2003-05-30 2004-05-19 Procedimiento para preparar el polimorfo i de hemisulfato de elitriptan anhidro, util en el tratamiento de condiciones para las cuales se indica un agonista de receptores 5-ht1, tal como migrana.
US10/852,038 US7132549B2 (en) 2003-05-30 2004-05-24 Process
TW093114789A TWI290923B (en) 2003-05-30 2004-05-25 Process for preparing a particular crystalline form of eletriptan hemisulphate
ARP040101864A AR044463A1 (es) 2003-05-30 2004-05-28 Proceso de preparacion de una forma cristalina de hemisulfato de eletriptan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0312478.1A GB0312478D0 (en) 2003-05-30 2003-05-30 Improved process

Publications (1)

Publication Number Publication Date
GB0312478D0 true GB0312478D0 (en) 2003-07-09

Family

ID=9959072

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0312478.1A Ceased GB0312478D0 (en) 2003-05-30 2003-05-30 Improved process

Country Status (10)

Country Link
EP (1) EP1633739A1 (pt)
JP (1) JP2006528968A (pt)
AR (1) AR044463A1 (pt)
BR (1) BRPI0410841A (pt)
CA (1) CA2527127A1 (pt)
CL (1) CL2004001132A1 (pt)
GB (1) GB0312478D0 (pt)
MX (1) MXPA05012838A (pt)
TW (1) TWI290923B (pt)
WO (1) WO2004106327A1 (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651637B2 (en) * 1990-10-15 1994-07-28 Pfizer Inc. Indole derivatives
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
WO1999001135A1 (en) * 1997-07-03 1999-01-14 Pfizer Limited Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
GB9922963D0 (en) * 1999-09-28 1999-12-01 Pfizer Ltd Polymorphic salt

Also Published As

Publication number Publication date
TWI290923B (en) 2007-12-11
TW200427683A (en) 2004-12-16
JP2006528968A (ja) 2006-12-28
CL2004001132A1 (es) 2005-03-18
EP1633739A1 (en) 2006-03-15
AR044463A1 (es) 2005-09-14
BRPI0410841A (pt) 2006-06-27
CA2527127A1 (en) 2004-12-09
WO2004106327A1 (en) 2004-12-09
MXPA05012838A (es) 2006-02-13

Similar Documents

Publication Publication Date Title
GB0320684D0 (en) Process
GB0319503D0 (en) Process
GB0306432D0 (en) Process
GB0322640D0 (en) Process
GB0313661D0 (en) Process
GB0316756D0 (en) Process
GB0303659D0 (en) Process
GB0317229D0 (en) Improved process
GB0314739D0 (en) Electrodeionisation process
GB0311725D0 (en) Process
GB0307259D0 (en) Process
GB0322648D0 (en) Process
GB0313110D0 (en) Process
GB0321240D0 (en) Process
GB0312451D0 (en) Process
GB0313031D0 (en) Process
GB0316872D0 (en) Process
GB0300733D0 (en) Process
GB0308672D0 (en) Process
GB0314960D0 (en) Process
GB0322559D0 (en) Process
GB0315498D0 (en) Improved process
GB0312478D0 (en) Improved process
GB0314493D0 (en) Process
GB0302863D0 (en) De-oxygenating process

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)